Format

Send to

Choose Destination
Sci Rep. 2015 Jun 10;5:11333. doi: 10.1038/srep11333.

Production of monoclonal antibodies against GPCR using cell-free synthesized GPCR antigen and biotinylated liposome-based interaction assay.

Author information

1
Proteo-Science Center, Ehime University, Ehime 791-8577, Japan.
2
Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama 930-0194, Japan.
3
Abnova (Taiwan) Corporation, Taoyuan County 320, Taiwan.
4
Cell-Free Sciences Co., Ltd., Ehime 791-8577, Japan.
5
Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
6
Graduate School of Medicine, Nagoya University, Aichi 466-8550, Japan.
7
Institute for the Promotion of Science and Technology, Ehime University, Ehime 791-8577, Japan.

Abstract

G-protein-coupled receptors (GPCRs) are one of the most important drug targets, and anti-GPCR monoclonal antibody (mAb) is an essential tool for functional analysis of GPCRs. However, it is very difficult to develop GPCR-specific mAbs due to difficulties in production of recombinant GPCR antigens, and lack of efficient mAb screening method. Here we describe a novel approach for the production of mAbs against GPCR using two original methods, bilayer-dialysis method and biotinylated liposome-based interaction assay (BiLIA), both of which are developed using wheat cell-free protein synthesis system and liposome technology. Using bilayer-dialysis method, various GPCRs were successfully synthesized with quality and quantity sufficient for immunization. For selection of specific mAb, we designed BiLIA that detects interaction between antibody and membrane protein on liposome. BiLIA prevented denaturation of GPCR, and then preferably selected conformation-sensitive antibodies. Using this approach, we successfully obtained mAbs against DRD1, GHSR, PTGER1 and T1R1. With respect to DRD1 mAb, 36 mouse mAbs and 6 rabbit mAbs were obtained which specifically recognized native DRD1 with high affinity. Among them, half of the mAbs were conformation-sensitive mAb, and two mAbs recognized extracellular loop 2 of DRD1. These results indicated that this approach is useful for GPCR mAb production.

PMID:
26061673
PMCID:
PMC4462149
DOI:
10.1038/srep11333
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center